Published May 2005
by Parexel International Corp. .
Written in English
|Contributions||Parexel International Corporation (Corporate Author)|
|The Physical Object|
|Number of Pages||389|
“‘New Drug Development: An Introduction to Clinical Trials, 2 nd Edition’ is a solid introduction to the process of drug development, with an emphasis on clinical research, especially the statistical aspects. It is ideal for readers interested in clinical research within the broader prideinpill.com: Springer-Verlag New York. This book acquaints students and practitioners in the related fields of pharmaceutical sciences, clinical trials, and evidence-based medicine with the necessary study design concepts and statistical practices to allow them to understand how drug developers plan and evaluate their drug development/5(2). Jul 18, · The development of new drugs is very complex, costly and risky. Its success is highly dependent on an intense collaboration and interaction between many departments within the drug development organization, external investigators and service providers, in constant dialogue with regulatory authorities, payers, academic experts, clinicians and patient organizations. Mar 01, · "The book gives a refreshing run through of the drug discovery and development process and it is probably the book you need to have to learn about this fascinating field." (Journal of Applied Statistics, January ).
New Drug Development: A Regulatory Overview by Mark Mathieu and a great selection of related books, art and collectibles available now at prideinpill.com "Go inside the drug development and FDA regulatory process with today's most authoritative and popular reference on the topic. In its all-new edition, New Drug Development: A Regulatory Overview addresses the most cutting-edge developments redefining how new drugs are developed and regulated today, including: how the FDA Amendments Act of will affect everything from drug reviews to. Go inside the drug development and FDA regulatory process with today's most authoritative and popular reference on the topic. In its all-new edition, New Drug Development: A Regulatory Overview addresses the most cutting-edge developments redefining /5(14). In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), /5().
Development Resources. FDA encourages sponsors to communicate with us well before they propose clinical trials for new drugs, especially for serious diseases, rare diseases, pediatric conditions. This book provides the most comprehensive and up-to-date analysis of FDA's new drug development process available today. I recommend this well-written book for professionals engaged in the drug development and review process. --Biopharm Magazine This book is superb! It is the single best source of information on the drug regulatory system/5(14). Apr 15, · Drug discovery and development is such a complex process to encompass in one reference book, but there are three best-sellers standing out as the most highly rated and comprehensive manuals on the topic today. “Active Pharmaceutical Ingredients: D. The cost of drug development is the full cost of bringing a new drug (i.e., new chemical entity) to market from drug discovery through clinical trials to approval. Typically, companies spend tens to hundreds of millions of U.S. dollars on drug development.